Metabolic Reprogramming

ROS induction targets persister cancer cells with low metabolic activity in NRAS-mutated melanoma

This study explores a new therapeutic approach for NRAS-mutated melanomas, targeting drug-resistant cells through ROS induction and metabolic vulnerabilities.